Published • loading... • Updated
Tempus AI (TEM) Stock Surges 92% Since July as CEO Reveals Medicare Revenue Projections
Summary by Blockonomi
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Tempus AI (TEM) Stock Roars Back 92% From July Low After CEO Lays Out Growth Plan
TLDR Tempus AI stock jumped 15% Thursday, extending its five-day gain to nearly 40% CEO Eric Lefkofsky expects up to $100M in revenue from its tissue scanning test and up to $300M from its liquid biopsy TEM has risen 92% since hitting a 52-week low of $41.55 on July 29 Wall Street holds a Moderate...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
